New Blood-Saving technique could transform liver surgery

NCT ID NCT07629648

Not yet recruiting Disease control Sponsor: Dr. Glenio Mizubuti (MD, PhD, FRCPC) Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a controlled blood removal method during liver surgery to see if it lowers the need for blood transfusions. About 60 adults having liver resection for cancer will take part. The approach involves removing a small amount of blood before surgery and giving it back afterward, along with careful monitoring and standardized care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: hypovolemic phlebotomy (controlled blood removal and reinfusion)
What this could lead to: If successful, this could reduce the need for blood transfusions during liver surgery, leading to fewer complications and faster recovery.
What could go wrong: This is a small, early-stage quality improvement project with only 60 participants. The approach may not work for all patients or may carry risks like unstable blood pressure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLOOD CELLS TRANSFUSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Blood Loss, Surgical cirrhosis of liver

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLOOD CELLS TRANSFUSION HEPATECTOMY INTRAOPERATIVE BLEEDING INTRAOPERATIVE MONITORING PHLEBOTOMY TRANSFUSION REQUIREMENTS

New Blood-Saving technique could transform liver surgery

Summary

What this could mean

Get notified about this study

Conditions

As listed by the trial registrant

Contacts and locations

Locations

More trials for these conditions